Archives for 18/08/2023

– Manuscript – U.S. officials gave full approval last week to Leqembi, a drug that moderately slows Alzheimer’s disease. The disease affects the brain causing memory loss and dementia. The Food and Drug Administration (FDA) approval means the government’s health coverage, Medicare, and other health insurance plans will help pay for the drug’s cost. The FDA approved … [Read more...] about US Approves Drug to Slow Early Effects of Alzheimer’s Disease